Rachel M. Layman, Katarzyna Joanna Jerzak, John Frederick Hilton, Pablo Tolosa Ortega, Alejandro Martinez Bueno, Stephen K.L. Chia, Meritxell Bellet, Jo Chien, Colombe Chappey, Hechuan Wang, Shaparak Lonning, Noah C. Berkowitz, Yuanyuan Zhang, Joseph Francis Kleha, Cynthia X. Ma. "Vepdegestrant, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, plus abemaciclib (ABE) in ER+/human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): TACTIVE-U phase 1b/2 results.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1067